Drug Type ASO |
Synonyms RG 6004, RG6004 |
Target- |
Action- |
Mechanism RNA interference |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hepatitis B, Chronic | Phase 1 | China | 06 Feb 2017 | |
| Hepatitis B, Chronic | Phase 1 | Australia | 06 Feb 2017 | |
| Hepatitis B, Chronic | Phase 1 | New Zealand | 06 Feb 2017 | |
| Hepatitis B, Chronic | Phase 1 | Singapore | 06 Feb 2017 | |
| Hepatitis B, Chronic | Phase 1 | South Korea | 06 Feb 2017 | |
| Hepatitis B, Chronic | Phase 1 | Thailand | 06 Feb 2017 | |
| Hepatitis B | Phase 1 | Switzerland | - | |
| Hepatitis B | Phase 1 | - | - |





